Health Professional Human Clinical Trial Inquiries

QBiotics Ltd is not able to provide treatment with EBC-46 at this time. Recruitment for the two Phase I safety studies in Australia and New Zealand is now closed and QBiotics does not currently have any other open trials. QBiotics will proceed to analyse and report on the Phase I studies, and then make a determination on how best to continue with clinical development for eventual approval of EBC-46. Details of any future clinical trials will be posted on the company’s website and international clinical trial registries, such as ClinicalTrials.gov.